Endoscopy in patients with anticoagulant and antiplatelet therapy

1. Anderson MA, Ben-Menachem T, Gan SI et al. Management of antithrombotic agents for endoscopic procedures. Gastro­intest Endosc 2009; 70(6): 1060–1070.

2. American Society for Gastrointestinal endo­scopy. ASGE Standards of Practice Committee. (www.asge.org).

3. Al-Haddad M, Gill KR, Raimondo M et al. Safety and efficacy of cytology brushings versus standard fine-needle aspiration in evaluating cystic pancreatic le­sions: a controlled study. Endoscopy 2010; 42(2): 127–132.

4. Ansell J, Hirsch J, Poller L et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl 3): 204S–233S.

5. Blacker DJ, Wijdicks EFM, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 2003; 61(7): 964–968.

6. Boustiere C, Veitch A, Vanbiervliet G et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endo­scopy (ESGE) guideline. Endoscopy 2011; 43(5): 445–458.

7. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prosthesis. Circulation 1994; 89(2): 635–641.

8. Cao Y, Liao C, Tan A et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41(9): 751–757.

9. Cappell MS, Abdullah M. Management of gastrointestinal bleeding induced by gastro­intestinal endoscopy. Gastroenterol Clin North Am 2000; 29(1): 125–167.

10. Cho-S-J, Choi IJ, Kim CG et al. Aspirin use and bleeding riskafter endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 2012; 44(2): 114–121.

11. Choudari CP, Rajgopal C, Palmer KR. Acute gastrointestinal haemorrhage in anticoagulated patiens: diagnosis and response to Endoscopic treatment. Gut 1994; 35(4): 464–466.

12. Coronel M, Banner K, Nannegari V et al. Does aspirin increase the risk of bleeding for percutaneous endoscopic gastrostomy procedure? Gastrointest Endosc 2006; 63: AB113.

13. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complica­tions and their management: an attempt at consensus. Gastrointest Endosc 1991; 37(3): 383–393.

14. Friedland S, Sedehi D, Soetikno R. Colonoscopic polypectomy in anticoagulated patients. World J Gastroenterol 2009; 15(16): 1973–1976.

15. Dumonceau J-M, Andriulli A, Deviere J et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42(6): 503–515.

16. Garcia DA, Regan S, Henault LE et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008; 168(1): 63–69.

17. Gershlick AH, Richardson G. Drug eluting stents. BMJ 2006; 333(7581): 1233–1234.

18. Gerson LB, Gage BF, Owens DK et al. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Am J Gastroenterol 2000; 95(7): 1717–1724.

19. Gerson LB, Tokar J, Chiorean M et al. Complications associated with double balloon enteroscopy at nine US centers. Clin Gastro­enterol Hepatol 2009; 7(11): 1177–1182.

20. Guidelines of the French Society for Digestive Endoscopy (SFED). Management of Patients on Anticoagulants or Antiplatelet Agents before Digestive Endoscopy. Endo­scopy 2006; 38: 632–638.

21. Harrison RW, Ortel TL, Becker RC. To bridge or not to bridge: these are the questions. J Tromb Trombolysis; DOI 10.1007//s11239-012-0732-8.

22. Heresbach D, Kornhauser R, Seyrig JA et al. A national survey of endoscopic mucosal resection for superficial gastro­intestinal neoplasia. Endoscopy 2010; 42(10): 806–813.

23. Hui AJ, Wong RM, Ching JY et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59(1): 44–48.

24. Hui CK, Lai KC, Yuen MF et al. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding? Aliment Pharmacol Ther 2002; 16(5): 929–936.

25. Hussain N, Alsulaiman R, Burtin P et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007; 25(5): 579–584.

26. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293(17): 2126–2130.

27. Irani S, Arai A, Ayub K et al. Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastro­intest Endosc 2009; 70(5): 923–932.

28. King SB 3^rd, Smith SC Jr, Hirshfeld JW Jr et al. 2007 focused update of the ACC//AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008; 51(2): 172–209.

29. Kouklakis G, Mpoumponaris A, Gato­poulou A et al. Endoscopic resection of large pedunculated colonic polyps and risk of postpolypectomy bleeding with adrenaline injection versus endoloop and hemoclip: a prospective, randomized study. Surg Endosc 2009; 23(12): 2732–2737.

30. Kwan V, Bourke MJ, Williams SJ et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vas­cular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 2006; 101(1): 58–63.

31. Malik P, Yamashita B, Larson L et al. Comparison of various periprocedure anticoagulation approaches for elective colono­scopy: a cost modeling study. Gastro­intest Endosc 1999; 49: AB197.

32. Metman EH, Lagasse JP, d’Alteroche L et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 1999; 94(5): 1179–1185.

33. Okada K, Yamamoto Y, Kasuga A et al. Risk factors for delayed bleeding after endo­scopic submucosal dissection for gastric neoplasm. Surg Endosc 2011; 25(1): 98–107.

34. Ono S, Fujishiro M, Niimi K et al. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-­platelet agents. Dig Liver Dis 2009; 41(10): 725–728.

35. Penka M, Gumulec J, Bulíková A et al. Monitorování perorální antikoagulační léčby v ambulantní praxi. Kardiol Rev 2007; 9(3): 159–164.

36. Remedia Compendium. Panax 1999. www.panax.cz.

37. Richter J, Patrie J, Richter R et al. Use of high-dose aspirin or clopidogrel before or after percutaneous endoscopic gastro­stomy is not associated with post-procedural bleeding. Gastrointest Endosc 2010; 71: AB114.

38. Ruthmann O, Seitz A, Richter S et al. Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation. Chirurg 2010; 81(3): 247–254.

39. Sawhney MS, Salfiti N, Nelson DB et al. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008; 40(2): 115–119.

40. Sendino O, Fernández-Esparrach G, Solé M et al. Endoscopic ultrasonography- guided brushing increases cellular diagnosis of pancreatic cysts: A prospective study. Dig Liver Dis 2010; 42(12): 877–881.

41. Singh M, Mehta N, Murthy UK et al. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. Gastrointest Endosc 2010; 71(6): 998–1005.

42. Shiftman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patiens taking aspirin or other NSAIDs. Gastrointest Endosc 1994; 40(4): 458–462.

43. Stein RD, Alpert IS, Copeland J et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992; 102 (4 Suppl): 445s–455s.

44. Thomas T, Bebb J, Mannath J et al. ­EUS-guided pancreatic cyst brushing: a comparative study in a tertiary referral centre. JOP 2010; 11(2): 163–169.

45. Tsuji Y, Ohata K, Ito T et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastro­enterol 2010; 16(23): 2913–2917.

46. Veitch AM, Baglin TP, Gershlick AH et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008; 57(9): 1322–1329.

47. Wang MQ, Sze DY, Wang ZP et al. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001; 12(4): 465–474.

48. Williams DO, Abbott JD, Kip KE. DEScover Investigators. Outcomes of 6906 pa­tients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 2006; 114(20): 2154–2162.

49. Yousfi M, Gostout CJ, Baron TH et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99(9): 1785–1789.